QUARTERLY M&A ACTIVITY: In Q4 2025, Oaklins S&W facilitated over 15 transactions across a variety of sectors, driving growth amid economic complexi...
Read articleQUARTERLY M&A ACTIVITY: In Q4 2025, Oaklins S&W facilitated over 15 transactions across a variety of sectors, driving growth amid economic complexi...
Read articleDuring challenging times, one of the most important things is to surround ourselves with knowledgeable and supportive people. Today, we want to sha...
Read articleOaklins Smith & Williamson advised skin cancer screening specialist The Mole Clinic on its sale to private equity backed Sk:n
Read articleDuring challenging times, one of the most important things is to surround ourselves with knowledgable and supportive people. Today, we want to shar...
Read articleCurious to know what the new normal may look like, how COVID-19 is transforming industries and how this will affect our businesses and our lives? W...
Read article